Finance

Lists
MRKR:NASDAQ
Marker Therapeutics Inc
$1.39
+13.93%
(+0.17) 1D
$1.37
-1.44% (-0.020)
After hours
Closed: Aug 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
$1.25
High
$1.44
Low
$1.25
Mkt. cap
23.18M
Avg. vol.
52.87K
Volume
99.38K
52-wk high
$2.46
52-wk low
$0.81
EPS
-$0.66
Beta
1.50
Shares outstanding
16.67M
No. of employees
5
Open
$1.25
High
$1.44
Low
$1.25
Mkt. cap
23.18M
Avg. vol.
52.87K
Volume
99.38K
52-wk high
$2.46
52-wk low
$0.81
EPS
-$0.66
Beta
1.50
Shares outstanding
16.67M
No. of employees
5
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitemarkertherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to MRKR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MRKR in the last 3 months.
Highest
Current $1.39
$10.00 (+619.42%)
Average
$9.00 (+547.48%)
Lowest
$8.00 (+475.54%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$10.00
+619.4%
08/20/2026
John Newman
Canaccord Genuity
Buy
Maintained
$8.00
+475.5%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.23M
1.10M
751.69K
681.58K
Cost of goods sold
2.35M
2.14M
2.84M
-
Cost of revenue
2.35M
2.14M
2.84M
-
Research and development expenses
-
-
-
1.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
846.61K
1.23M
1.14M
Operating expense
1.02M
846.61K
1.23M
2.62M
Total operating expenses
3.37M
2.99M
4.07M
2.62M
Operating income
-2.14M
-1.88M
-4.07M
-2.62M
Other non operating income
-
-
760.37K
681.58K
EBT including unusual items
-2.00M
-1.72M
-3.18M
-1.83M
EBT excluding unusual items
-2.00M
-1.72M
-3.18M
-1.83M
Income tax expense
-
-15.16K
-
-
Effective tax rate
-
0.88%
-
-
Other operating expenses
-
-
-
-
Net income
-2.00M
-1.70M
-3.18M
-1.83M
Net profit margin
-162.11%
-154.35%
-
-
Earnings per share
-0.12
-0.04
-0.16
-0.09
Interest and investment income
138.06K
165.63K
132.89K
112.56K
Interest expense
-
-
-
-
Net interest expenses
138.06K
165.63K
132.89K
112.56K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps